Latest News and Press Releases
Want to stay updated on the latest news?
-
— CASGEVY™ approved in the U.S., European Union, Great Britain, the Kingdom of Saudi Arabia and Bahrain — — Clinical trials ongoing for next generation CAR T product candidates, CTX112™ and CTX131™...
-
Visiongain has published a new report entitled Biobanking Market Report 2024-2034: Forecasts by Ownership (National/Regional Agencies, Universities, Non-profit, Private), by Product and Service...
-
2023 Total Revenue of $434 million, Crysvita® revenue of $328 million and Dojolvi® revenue of $71 million 2024 Financial Guidance: Total Revenue between $500 million and $530 million, Crysvita...
-
LOS ANGELES, Feb. 13, 2024 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL), today announced financial results for the fourth quarter and full year ended December 31, 2023. "BlackLine closed the...
-
Quarter End AUM of $31.1 billion; Average AUM of $29.5 billion for the Fourth QuarterOperating Margin of 27.6% for the Fourth Quarter and 28.1% for full year 2023Fourth Quarter Fully Diluted EPS of...
-
Vancouver, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The global Marine Diesel Exhaust Fluid (MDEF) market size was USD 10.20 Billion in 2022 and is expected to register a rapid revenue CAGR of 8.0% during...
-
NEW YORK and WALTHAM, Mass., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (“Dianthus” or the “Company”) (NASDAQ: DNTH), a clinical-stage biotechnology company dedicated to advancing...
-
New York, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The dechlorination chemicals market is experiencing significant growth, driven by a combination of factors that include increasing awareness about water...
-
IRAK4 oral degrader KT-474 (SAR444656) expected to complete enrollment in both Phase 2 HS and AD studies in fourth quarter of 2024, with topline data expected in first half of 2025 ...
-
GREENWICH, Conn., Jan. 03, 2024 (GLOBE NEWSWIRE) -- GAMCO Investors, Inc. (“GAMI”) (OTCQX: GAMI) announced today that assets under management were $31.1 billion at December 31, 2023 as compared to...